...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221.
【24h】

miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221.

机译:miR-128b是MLL-AF4急性淋巴细胞白血病细胞中有效的糖皮质激素敏化剂,可与miR-221发挥协同作用。

获取原文
获取原文并翻译 | 示例

摘要

MLL-AF4 acute lymphocytic leukemia (ALL) has a poor prognosis. MicroRNAs (miRNA) are small noncoding RNAs that posttranscriptionally regulate expression of target mRNAs. Our analysis of previously published data showed that expression of miR-128b and miR-221 is down-regulated in MLL-rearranged ALL relative to other types of ALL. Reexpression of these miRNAs cooperatively sensitizes 2 cultured lines of MLL-AF4 ALL cells to glucocorticoids. Target genes down-regulated by miR-128b include MLL, AF4, and both MLL-AF4 and AF4-MLL fusion genes; miR-221 down-regulates CDKN1B. These results demonstrate that down-regulation of miR-128b and miR-221 is implicated in glucocorticoid resistance and that restoration of their levels is a potentially promising therapeutic in MLL-AF4 ALL.
机译:MLL-AF4急性淋巴细胞白血病(ALL)预后较差。 MicroRNA(miRNA)是小的非编码RNA,可在转录后调节靶mRNA的表达。我们对先前发表的数据的分析表明,相对于其他类型的ALL,miR-128b和miR-221的表达在MLL重排的ALL中被下调。这些miRNA的重新表达使2个培养的MLL-AF4 ALL细胞系对糖皮质激素敏感。 miR-128b下调的靶基因包括MLL,AF4,MLL-AF4和AF4-MLL融合基因; miR-221下调CDKN1B。这些结果表明,miR-128b和miR-221的下调与糖皮质激素抵抗有关,并且其水平的恢复是MLL-AF4 ALL的潜在有希望的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号